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Alkylglycerol mono-oxygenase (EC 1.14.16.5) forms a third,
distinct, class among tetrahydrobiopterin-dependent enzymes
in addition to aromatic amino acid hydroxylases and nitric
oxide synthases. Its protein sequence contains the fatty acid
hydroxylase motif, a signature indicative of a di-iron centre,
which contains eight conserved histidine residues. Membrane
enzymes containing this motif, including alkylglycerol mono-
oxygenase, are especially labile and so far have not been puriﬁed
to homogeneity in active form. To obtain a ﬁrst insight into
structure–function relationships of this enzyme, we performed
site-directed mutagenesis of 26 selected amino acid residues
and expressed wild-type and mutant proteins containing a C-
terminal Myc tag together with fatty aldehyde dehydrogenase
in Chinese-hamster ovary cells. Among all of the acidic residues
withintheeight-histidinemotif,onlymutationofGlu
137 toalanine
led to an 18-fold increase in the Michaelis–Menten constant
for tetrahydrobiopterin, suggesting a role in tetrahydrobiopterin
interaction. A ninth additional histidine residue essential for
activity was also identiﬁed. Nine membrane domains were
predicted by four programs: ESKW, TMHMM, MEMSAT and
Phobius. Prediction of a part of the structure using the Rosetta
membrane ab initio method led to a plausible suggestion for a
structure of the catalytic site of alkylglycerol mono-oxygenase.
Key words: alkylglycerol mono-oxygenase, fatty acid hy-
droxylase motif, phenylalanine hydroxylase, tetrahydrobiopterin,
transmembrane domain.
INTRODUCTION
Alkylglycerol mono-oxygenase (glycerylether mono-oxygenase,
EC 1.14.16.5) is the only enzyme known to cleave the ether
bond of alkylglycerols [1]. Alkylglycerols form an abundant
and diverse class of lipids and phospholipids of humans and
other animals and are thought to play a role in sperm and nerve
development, in protection of the eye from cataract and in signal
transduction of cytokines [2]. Alkylglycerol mono-oxygenase
might be important for theregulation of etherlipid concentrations
in vivo. Alkylglycerol mono-oxygenase is known to require
tetrahydrobiopterinforcatalysis[3].Thesequenceofthisenzyme
remained obscure for decades owing to its lability that precluded
its puriﬁcation. Using bioinformatic database searches and
recombinant expression of selected candidate genes, we recently
found a predicted membrane protein with unknown function to
encode alkylglycerol mono-oxygenase [4]. This sequence has no
similaritytoeitheroftheothertwoclassesoftetrahydrobiopterin-
dependent enzymes, the aromatic amino acid hydroxylases and
thenitricoxidesynthases[5],andthusformsathird,distinct,class
amongtetrahydrobiopterin-dependentenzymes[4].Thedetection
of the fatty acid hydroxylase motif in this sequence gave a
plausible explanation why puriﬁcation attempts had failed so far.
Proteins containing this motif are thought to contain a di-iron
centre for catalytic activity, and none of the membrane proteins
of this class which comprises hydroxylases and desaturases of
speciﬁc lipid and steroid substrates has, so far, ever been isolated
in active form [6].
Despite intense efforts, we also failed to isolate the enzyme in
activeform.Wesucceeded,however,inrecombinantexpressionof
a tagged version of the active protein in CHO (Chinese-hamster
ovary) cells, thus opening up the possibility to investigate the
contribution of speciﬁc amino acid residues to enzymatic activity
of the protein by site-directed mutagenesis. With this tool, we
had already shown the necessity of the eight conserved histidine
residues for alkylglycerol mono-oxygenase activity [4], and we
extend this analysis in the present study describing 26 further
mutations, including a residue which, when mutated, attenuates
tetrahydrobiopterin afﬁnity to the enzyme 18-fold.
NoproteinofknownstructureinthePDBshowedanysimilarity
to alkylglycerol mono-oxygenase, precluding the prediction of
a structure based on a known structure of a similar protein.
Since puriﬁcation and crystallization of this labile membrane
protein appeared remote for experimental reasons, we predicted
transmembrane domains and a structure of alkylglycerol mono-
oxygenase using the Rosetta membrane ab initio method
[7].
EXPERIMENTAL
Site-directed mutagenesis of selected residues in human
alkylglycerol mono-oxygenase
Human alkylglycerol mono-oxygenase in pEXPR-IBA103 (IBA)
harbouring a 6× Myc tag at the C-terminus [4] was used
as template. Selected residues were altered to alanine using
the QuikChange® site-directed mutagenesis kit (Stratagene).
Primer sequences are listed in Supplementary Table S1
at http://www.BiochemJ.org/bj/443/bj4430279add.htm. Correct
insertion of all mutations was conﬁrmed by DNA sequencing.
Abbreviations used: CHO, Chinese-hamster ovary; GFP, green ﬂuorescent protein.
1 To whom correspondence should be addressed (email ernst.r.werner@i-med.ac.at).
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Transfection of CHO-K1 cells with wild-type and mutant
alkylglycerol mono-oxygenase constructs
CHO-K1 (LGC Promochem) cells were plated in a six-well
plate at a density of 3.75×10
5 cells in 3 ml of medium per
well. After 24 h, two wells for each construct were transfected
with 1 μg of human alkylglycerol mono-oxygenase–6×Myc
plasmid DNA and 1 μg of human fatty aldehyde dehydrogenase
(GenBank® accession number NM_000382) in the pcDNA3.1+
expression vector (Invitrogen) using ExGen 500 (Fermentas)
following the manufacturer’s protocol. Transfection efﬁciency
was checked by GFP (green ﬂuorescent protein) expression
using N1-eGFP (Clontech Europe). Cells were cultivated at
37◦C under 5% CO2 in F-12K (Kaighn’s modiﬁcation of Ham’s
F12 medium) nutrient medium (Invitrogen), supplemented with
10% (v/v) heat-inactivated fetal bovine serum (PAN Biotech) in
t h ep r e s e n c eo f1μM tetrahydrobiopterin precursor sepiapterin
(Schircks Laboratories). After 48 h, cells were harvested by
trypsinization. Cells transfected with wild-type enzyme and
cells transfected with GFP (both co-transfected with human
fatty aldehyde dehydrogenase) were prepared and analysed in
parallel to serve as positive and negative controls respectively.
Formembranepreparation,cellsweresuspendedindistilledwater
containing 1× protein inhibitor mixture (GE Healthcare), snap-
frozen and stored at −80◦C until analysis.
Alkylglycerol mono-oxygenase activity assay
Enzymatic activity was measured in supernatants of transfected
cells harvested and shock frozen in 0.5% CHAPS (Sigma). After
thawing, mixing and centrifuging at 16000 g for 5 min at 4◦C,
supernatants were incubated with 1-O-pyrenedecyl-sn-glycerol
(chemically synthesized from pyrenedecanoic acid and glycerol
as described in [8]), 0.2 mM tetrahydrobiopterin (Schircks
Laboratories), 0.2 μg/ml (0.5 μmol/ml per min) recombinant
dihydropteridine reductase from Physarum polycephalum [9],
0.1 mg/ml catalase (Sigma), 20 μmol·ml
−1·min
−1 recombinant
rat fatty aldehyde dehydrogenase [10], 0.2 mM NAD (Sigma)
and 0.2 mM NADPH (Sigma) in 100 mM Tris/HCl (pH 8.5) for
60 min at 37◦C in a total volume of 10 μl. The reaction was
started by the addition of protein and stopped by adding 30 μl
of methanol. After centrifugation at 16000 g for 5 min, 10 μlo f
the resulting mixture was injected on to a Zorbax XDB-C8
rapid resolution column (Agilent Technologies) using an Agilent
1200 Series HPLC system. Elution was performed at a ﬂow
rate of 1 ml/min starting with a mixture of 21% (v/v) 10 mM
potassium phosphate buffer (pH 6.0) and 79% (v/v) methanol for
4.5 min followed by a gradient to 100% methanol at 5.0 min.
At 8.0 min, the 21:79 buffer/methanol mixture was re-established
and the column was equilibrated for 30 s before starting the next
run. Pyrenedecanoic acid was detected by ﬂuorescence (340 nm
excitation and 400 nm emission, detection limit 1 nM [8]). Fatty
aldehyde dehydrogenase was provided both by transfection and
in the assay mixture to ensure complete conversion of the
intermediate product from the alkylglycerol mono-oxygenase
reaction, the ﬂuorescent aldehyde, into the detected compound
pyrenedecanoic acid. Negative controls without protein (concen-
tration of pyrenedecanoic acid <1 nM) and rat liver microsomes
aspositivecontrolswerealwaysruninparallel.Fordetermination
of Km values, cell extracts were incubated with assay mixtures
containing 0, 10, 30 or 100 μM tetrahydrobiopterin or 0, 1, 3, 10,
30 or 100 μM1 - O-pyrenedecyl-sn-glycerol.
The iron afﬁnity of wild-type and E137A mutant alkylglycerol
mono-oxygenase was tested using a phenanthroline inhibition
assay.Thismethodwaschosenonthebasisofpreviousresults[11]
showing no further increase in alkylglycerol mono-oxygenase
activity upon addition of iron. Cell extracts were diluted 1:10
in increasing amounts (assay end concentration ranging from
33.75 nM to 3.375 mM) of the iron chelator phenanthroline
in an optimized buffer containing 50 mM triethanolamine/HCl
(pH 7.5), 150 mM NaCl, 10% (v/v) glycerol, 10 mM ascorbic
acid and 20 μM tetrahydrobiopterin. Mixtures were shaken at
25◦C for 15 min and were subsequently subjected to the standard
activity assay, but in the presence of 0.4 mM tetrahydrobiopterin
to saturate the E137A mutant with the cofactor. For at least
three separate sets of experiments, curves were ﬁtted to the data
using GraphPad Prism 5.03, and the concentrations yielding
half-maximal activity or 50% inhibition were taken as Km or
IC50 respectively.
Phenylalanine hydroxylase activity assay and iron-binding studies
Recombinant rat liver phenylalanine hydroxylase was expressed
as a maltose-binding protein-fusion protein, puriﬁed by afﬁnity
chromatography [11]. The E286A mutation was introduced using
the QuikChange® site-directed mutagenesis kit, and the identity
of the mutation was conﬁrmed by DNA sequencing. Primer
sequences are given in Supplementary Table S1. Phenylalanine
hydroxylase proteins (0.5 mg/ml) were pre-incubated with
increasing concentrations of phenanthroline in the presence of
1.2 mM phenylalanine, 1.2 mg/ml catalase [freed from low-
molecular-mass compounds by gel ﬁltration over NAP5 columns
(GE Healthcare)] in 60 mM Hepes buffer (pH 7.0) for 15 min
at 25◦Ci n3 0μl. The reaction was started by the addition of
6 μl of a solution containing 30 mM each of tetrahydrobiopterin
and dithioerythritol to yield ﬁnal concentrations of 5 mM
tetrahydrobiopterin (to also saturate the E286A mutant with
the cofactor), 1 mM phenylalanine, 1 mg/ml catalase and 5 mM
dithioerythritol in 50 mM Hepes (pH 7.0). After incubation for
20 minat37◦C,thereactionwasstoppedbytheadditionof3.6 μl
of 40% (w/v) trichloroacetic acid. Tyrosine concentrations were
measured after reversed-phase HPLC with ﬂuorescence detection
(275 nm excitation, 310 nm emission) as described in [11].
Preparation of membrane fractions and Western blotting
Membranefractionsofthecellswerepreparedasdescribedin[4],
protein concentration was determined using the Bradford assay
with BSA as standard. To quantify the amount of recombinant
tagged protein formed, Western blots were performed as
described in [4]. In short, 40 μg of microsomal protein was
s e p a r a t e db yS D S / P A G E( 1 0 % gels), transferred on to PVDF
membranes and stained with rabbit polyclonal anti-c-Myc (A-14)
antibody (1:1000 dilution; Santa Cruz Biotechnology) and
horseradish-peroxidase-conjugated anti-(rabbit IgG) (1:10000
dilution; Pierce). Bands were visualized with the ECL (enhanced
chemiluminescence) Plus detection system (GE Healthcare)
and blots were scanned using a Typhoon 9410 scanner
(457 nm excitation, 520 nm emission, 40 nm band pass, 500 V
photomultiplier voltage; GE Healthcare). Wild-type and mutant
alkylglycerol mono-oxygenase activities were normalized on
Western blot band pixel count quantiﬁed with ImageQuant TL
software (GE Healthcare).
Consensus sequence of alkylglycerol mono-oxygenase from
11 animal species
Alkylglycerolmono-oxygenasesequencesfrom11animalspecies
(Rattus norvegicus, Mus musculus, Bos taurus, Equus caballus,
Danio rerio, Pan troglodytes, Xenopus tropicalis, Macaca
c   The Authors Journal compilation c   2012 Biochemical Society © 2012 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.Alkylglycerol mono-oxygenase catalytic residues and predicted structure 281
Figure 1 Transmembrane regions and residues mutated in alkylglycerol mono-oxygenase
Transmembrane (TM) regions 1–5 as well as the helix spanning residues 139–150 were taken from ab initio predicted structures (see Figure 5). Transmembrane regions 6–9 and the helix spanning
residues 270–290 were assigned as a consensus from four programs (ESKW, TMHMM, MEMSAT and Phobius). The symbols indicate the position of amino acids residues mutated. Residues with
white frames and black ﬁlling are those that led to a total loss of enzymatic activity of the recombinant protein expressed in CHO cells. Upward-pointing triangles indicate the eight-histidine motif
[4,25], downward-pointing triangles indicate further histidine residues that were mutated. The hexagon shows the position of Glu137 which is important for tetrahydrobiopterin interaction. Circles
show positions of acidic residues (aspartate and glutamate) mutated, squares indicate other mutated residues. The region of the active site and the presumed di-iron centre is highlighted in grey.
mulatta, Gallus gallus and Strongylocentrotus purpuratus and
Homo sapiens) were aligned by the ClustalW module of Mega
4.0 [12], using the identity option and all other parameters as
default values. Sequences were taken from the protein database
of the National Center for Biotechnology Information (NCBI).
Assignment of transmembrane regions
Transmembrane predictions are a consensus from four programs:
ESKW [13], TMHMM [14], MEMSAT [15] and Phobius [16]
for alkylglycerol mono-oxygenase sequences available from
animal species, showing a consistent picture of nine conserved
transmembrane regions predicted.
Rosetta ab initio prediction of an alkylglycerol mono-oxygenase
structure
The Rosetta ab initio method is based on the assumption that the
native state of a protein is at the global free energy minimum and
uses structural information for short protein fragments (extracted
from the PDB) to sample local conformations adopted by these
fragments [17–19]. Speciﬁcally, structural fragment libraries for
each three- and nine-residue segment of protein sequence of
interest are extracted from the PDB using a sequence proﬁle
comparison method that uses multiple sequence alignment of
the homologous segments. The Rosetta membrane environment-
speciﬁc energy function favours burial of small hydrophobic
residues and exposure of large hydrophobic residues within
the hydrophobic layer of the membrane together with minimizing
hydrophobic residue exposure in the polar environment outside
the membrane [7]. The membrane environment is simulated
using an energy function derived from statistics generated from
known high-resolution membrane protein structures [7]. This
membrane environment-speciﬁc energy function includes residue
environment, residue–residue interactions and residue density
terms. The residue environment term is based on amino acid
propensities to be in distinct membrane layers (hydrophobic,
interface, polar and water) and depends on the residue burial
state, from being completely buried within a protein environment
to being completely exposed either to the lipid or water
environments. Residue–residue interaction terms are based on
the propensities of amino acid pairs to be in close proximity
to each other within hydrophobic and polar layers. The residue
density term is based on the distribution of the number
of residue neighbours within 6 and 12 Å (1 Å=0.1 nm)
spheres in native membrane protein structures. The membrane
environment-speciﬁc full atom energy function is similar to the
energy function used for modelling of water-soluble proteins
[20], except that solvation and hydrogen-bond potentials are
functions of residue depth in the membrane. The membrane
environment is described by two isotropic phases (water and
hydrocarbon layers) and an anisotropic phase (interface layer)
that interpolates the chemical properties of the two isotropic
phases.Animplicitatomicsolvationpotentialforthehydrophobic
layer is based on experimental transfer free energies of peptides
from water to lipid bilayers [21]. The atomic solvation energies
in the water environment are based on a solvation model
developed by Lazaridis and Karplus [22]. The atomic solvation
energies in the membrane interface layer were derived by
interpolating the solvation properties between hydrophobic and
water layers using sigmoidal function. We applied the Rosetta
membrane ab initio method to modelling of human alkylglycerol
mono-oxygenase. Transmembrane helix topology of human
alkylglycerol mono-oxygenase was predicted using the methods
described above, and all ﬁve predicted transmembrane regions
for the Pro
37–Ile
205 region were required to span the membrane
during modelling. A total of 5000 low-resolution de novo models
of human alkylglycerol mono-oxygenase were generated using
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the Rosetta membrane ab initio method followed by model
clustering as described previously [23]. Centre models from each
of the ﬁve largest clusters were subjected to all-atom reﬁnement
protocol [24], and the best model was chosen on the basis
of available experimental data. Expansion of the prediction to
fully cover the eight-histidine motif [25] did not yield consistent
models, as inclusion of further transmembrane regions inﬂated
dimensionality of structure prediction. The co-ordinates of the
predicted structure for residues Pro
37–Ile
205 are available in PDB
format at http://www.BiochemJ.org/bj/443/bj4430279add.htm.
Presentation of data and statistical analysis
Resultsarepresentedasmeans+ −S.E.M.fortheindicatednumber
of independent experiments. Statistical analysis using Student’s
or one sample t test was performed using GraphPad Prism 5.03.
P values <0.05 were considered signiﬁcant.
RESULTS
Loss-of-function mutants
We have shown previously that all eight histidine residues
representing the fatty acid hydroxylase motif are essential for
the enzymatic activity of alkylglycerol mono-oxygenase [4]. We
now expanded this investigation to another 26 conserved residues
ranging from position 125 to position 397 of the human protein
sequence (Figure 1). In addition to the eight histidine residues,
weidentiﬁedsevenfurtherresidues(Gln
162,His
201,Asp
233,Asn
235,
Tyr
236,T r p
243 and Asp
244) which caused a total loss of activity
when mutated to alanine (Figures 1 and 2). Depending on the
amount of protein expressed, the detection limit was 1–5% of
wild-type activity. Three of these amino acids (His
201,T r p
243 and
Asp
244) are conserved among all animal members of the fatty acid
hydroxylase family [4].
Mutants with residual enzyme activity
In six of the mutants (Q146A, D153A, H220A, Y230A, C231A
andC397A),activitywasnotsigniﬁcantlydifferentfromcontrols.
None of the tested mutations yielded activity levels higher than
that of wild-type (Figure 2). Twelve mutants had signiﬁcantly
reduced, but clearly detectable, enzyme activity (E137A, E152A,
Q166A, Y174A, H189A, Q191A, Q197A, E203A, E212A,
Y338A, D384A and R396A) (Figure 2). Two of these mutants
(Q197A and Y338A) had an activity of less than 5% of that of
controls, which was nevertheless signiﬁcantly higher than control
valuesowingtogoodproteinexpressionofthemutants(Figure2).
Mutants with decreased protein expression
Eight of the mutant plasmids yielded signiﬁcantly lower amounts
of protein, ﬁve of them expressed less than half of the protein
amount compared with wild-type (D125A, N235A, Y236A,
W243A and D244A). In D125A, the amount of protein expressed
was too low for a reliable quantiﬁcation, and therefore this
mutant was excluded from activity analysis (Figure 2).
Investigation of selected mutants for tetrahydrobiopterin
interaction
Within the region of the conserved essential eight-histidine
motif [25] which comprises residues 132–225 of human
alkylglycerol mono-oxygenase, the catalytic core of the enzyme,
we then selected mutants of all glutamate and aspartate
residues (E137A, E152A, D153A, E203A and E212A) and
Figure 2 Enzymatic activities of 25 mutant alkylglycerol mono-oxygenase
proteins expressed in CHO cells
(A) Alkylglycerol mono-oxygenase activity of individual experiments for 25 mutations were
normalized to band pixels from Western blots and are shown in relation to wild-type activity
measured in parallel experiments. One mutant (D125A) did not express detectable protein
and was excluded from activity evaluation. Asterisks indicate signiﬁcant differences from
100% wild-type level (P <0.05). Results are means+ −S.E.M. for at least three experiments.
(B) Representative Western blots of membrane fractions of all 26 mutant alkylglycerol
mono-oxygenase proteins after heterologous transfection in CHO cells. Mock indicates cells
transfected with human fatty aldehyde dehydrogenase and GFP. Protein marker bands are
indicated on the left-hand side of each blot (with sizes given in kDa). For the blot of H201A,
wild-type (WT) and mock lanes were separated from the mutant on the original blot by other
samples which were cut out for clarity as indicated by the lines in the Figure. (C) Expression of
recombinant proteins quantiﬁed from scans from at least three experiments. Asterisks indicate
signiﬁcant differences from 100% wild-type level (P <0.05).
an additional histidine mutant (H189A), which all had
detectable residual activity. We tested these mutants for
theirconcentration-dependenceofalkylglycerolmono-oxygenase
activity with respect to tetrahydrobiopterin and 1-O-pyrenedecyl-
sn-glycerol. Cell extracts expressing wild-type enzyme were
chosen as controls. Although no signiﬁcant changes could
be detected in the afﬁnity of mutants towards the substrate
(Figure 3A), mutant E137A had an 18.3-fold increased
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Figure 3 Michaelis–Menten constants of six selected mutant proteins for tetrahydrobiopterin and 1-O-pyrenedecyl-sn-glycerol
The selected residues include all glutamate and aspartate residues within the conserved eight-histidine motif. CHO cells transfected with wild-type and mutant alkylglycerol mono-oxygenase
were incubated with increasing amounts of tetrahydrobiopterin (H4- b i o p t e r i n )o r1 - O-pyrenedecyl-sn-glycerol. Activities were quantiﬁed by analysis of pyrenedecanoic acid with HPLC. (A)
Michaelis–Menten constants for the substrate 1-O-pyrenedecyl-sn-glycerol (n=3). (B) Michaelis–Menten constants for tetrahydrobiopterin (H4-biopterin) from three independent experiments.
*P <0.05, relative to wild-type constants. (C) Tetrahydrobiopterindependenceof wild-type (continuousline, ) and E137A(broken line, ), linear representation.(D) Double-reciprocalplot of the
data shown in (C).
Km value for tetrahydrobiopterin in comparison with wild-
type (33.5+ −8.79 μM compared with 1.83+ −0.38 μM; n=3;
P<0.05; Figure 3B). Figures 3(C) and 3(D) show the original
data for tetrahydrobiopterin-dependence of the activity in E137A
mutantandwild-typeenzymes,innormalandindoublereciprocal
plotting respectively.
Iron afﬁnity of wild-type and E137A alkylglycerol mono-oxygenase
To check whether mutant E137A also displayed a different
afﬁnity not only for tetrahydrobiopterin, but also for iron, which
is essential for catalysis [11], we incubated E137A- and wild-
type-transfected CHO cell extracts with increasing amounts
of the iron chelator phenanthroline and subsequently assayed
their residual alkylglycerol-cleaving ability. Activity of both
wild-type alkylglycerol mono-oxygenase and the E137A mutant
alkylglycerol mono-oxygenase were competitively inhibited by
phenanthroline (Figure 4A). IC50 values for mutant E137A
(0.69+ −0.19 μM; n=5) were 5-fold lower than values for wild-
type (3.41+ −0.64 μM; n=5; P<0.01). Thus the E137A mutant
of alkylglycerol mono-oxygenase had an approximately 5-fold
lower afﬁnity for iron.
Iron afﬁnity of wild-type and E286A phenylalanine hydroxylase
Since iron afﬁnity of the phenylalanine hydroxylase E286A
mutant which also displays a highly increased Km value for
tetrahydrobiopterin ([26], and see the Discussion) had not been
investigated so far, we investigated iron binding of this mutant
in comparison with the wild-type enzyme with a similar phenan-
throlinecompetitionactivityassayusingrecombinantEscherichia
coli-expressed enzymes for comparative purposes (Figure 4B).
Both wild-type and mutant phenylalanine hydroxylase were
inhibited by phenanthroline. The corresponding IC50 values for
phenanthroline were 6.37+ −0.23 μM for the E286A mutant
phenylalanine hydroxylase and 15.7+ −1.51 μM for the wild-
type phenylalanine hydroxylase (n=3 each; P<0.01). Thus
the E286A mutation in phenylalanine hydroxylase led to an
approximately 2.5-fold decrease in iron afﬁnity.
Ab initio predicted structure of alkylglycerol mono-oxygenase
Figure 5 shows the structure of residues 37–205 modelled by
Rosetta Membrane. Even though no information on residues
critical for protein function were used for model generation, all
residues leading to a total loss of enzyme activity upon alanine
mutation are found in close spatial proximity. Moreover, all ﬁve
histidine residues of the eight-histidine motif covered in the mod-
elledregion,aswellasthehighlyconservedHis
201,formashallow
cavity ready to accommodate a catalytically active iron cluster
that could not be included in the actual model. Glu
137, the residue
involved in the interaction with tetrahydrobiopterin, is found in a
ﬂexible loop region close to the histidine motif at the surface of
the predicted partial structure accessible for the cofactor.
DISCUSSION
The present paper is a ﬁrst report on structure–function
relationships of alkylglycerol mono-oxygenase, the only enzyme
known to cleave the ether bond of alkylglycerols. Owing to the
instability inherent to the membrane proteins containing the fatty
acid hydroxylase motif, neither alkylglycerol mono-oxygenase
nor a similar protein of this family has ever been puriﬁed, and
therefore also no structures of similar proteins are available in
databases. Even the sequence of alkylglycerol mono-oxygenase
has only been assigned recently by recombinant expression of
bioinformatically selected candidate genes [4]. In the present
study, we investigated the impact of mutation of conserved
residues on alkylglycerol mono-oxygenase activity, identiﬁed
aresidueimportantfortetrahydrobiopterininteractionandpresent
an ab initio predicted structure of a part of the enzyme.
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Figure 4 Inﬂuence of tetrahydrobiopterin-afﬁnity-lowering glutamate to
alanine mutations on iron afﬁnity in alkylglycerol mono-oxygenase and
phenylalanine hydroxylase
(A) Dependence of enzymatic activity of wild-type and E137A alkylglycerol mono-oxygenase
on concentrations of the iron chelator phenanthroline. Extracts of CHO cells transfected
with wild-type (continuous line, ) and E137A mutant (broken line, ) alkylglycerol
mono-oxygenasewereincubatedfor15minat25◦Cwithincreasingamountsofphenanthroline.
Alkylglycerol mono-oxygenase activities were quantiﬁed by analysis of pyrenedecanoic acid
formation by HPLC with ﬂuorescence detection in presence of 0.4mM tetrahydrobiopterin.
Activity of the lowest phenanthroline concentration was set to 100%. Under standard assay
conditions,theE137Amutantshows12.8+ −4.8%ofenzymaticactivitycomparedwithwild-type
alkylglycerolmono-oxygenase(Figure2).Resultsaremeans+ −S.E.M.(n=5).(B)Dependence
of enzymatic activity of wild-type and E286A mutant phenylalanine hydroxylase on concen-
trations of phenanthroline. Recombinant wild-type (continuous line, ) and E286A mutant
(broken line, ) rat phenylalanine hydroxylase were incubated for 15 min at 25◦C with
increasing amounts of phenanthroline. Phenylalanine hydroxylase activity was measured by
monitoring the formation of tyrosine by HPLC with ﬂuorescence detection in the presence of
5 mMtetrahydrobiopterin.Activityofthelowestphenanthrolineconcentrationwassetto100%.
Under standard assay conditions with 5 mM tetrahydrobiopterin, the E286A mutant showed
7.9+ −1.4% of enzymatic activity compared with wild-type phenylalanine hydroxylase. Results
are means+ −S.E.M. (n=3).
Earlier work showed that eight conserved histidine residues
are essential for the function of fatty acid hydroxylase motif-
containing enzymes [25], and these eight are required for
alkylglycerol mono-oxygenase activity [4]. However, when
analysingtheproteinsequences,threefurtherresidueswerefound
to be conserved among all investigated fatty acid hydroxylase
motif-containing animal proteins, including alkylglycerol mono-
oxygenase. These residues are His
201,T r p
243 and Asp
244 [4]. We
found that mutation of any of these residues also abolished
activity of alkylglycerol mono-oxygenase, suggesting that, in
addition to the eight histidine residues, these residues might be
necessary for fatty acid hydroxylase function in general. The two
further histidine residues conserved in all animal alkylglycerol
mono-oxygenase sequences, His
189 and His
220,h o w e v e r ,w e r en o t
essential for activity. All residues essential for enzymatic activity
cluster to a region which we consider to be the catalytic core of
the enzyme (see Figure 1).
In previous work, we have demonstrated that tetrahydrobiop-
terin interaction and metal-dependence of alkylglycerol mono-
oxygenase is similar to tetrahydrobiopterin-dependent aromatic
aminoacidhydroxylases,butdifferentfromnitricoxidesynthases
[11].Inaromaticaminoacidhydroxylases,aconservedglutamate
residue (Glu
286 in human phenylalanine hydroxylase) interacts
with tetrahydrobiopterin in the crystal structure [27]. Mutation
of this glutamate residue to alanine leads to a highly increased
Km value for tetrahydrobiopterin [26]. In the present study, we
mutated all glutamate and aspartate residues within the catalytic
site of alkylglycerol mono-oxygenase to alanine and assessed
the Km values of the mutants when expressed in CHO cells.
Only one of these mutants, E137A, had an 18-fold increased
Km value for tetrahydrobiopterin, whereas the Km values of all
other mutants selected for tetrahydrobiopterin were similar to
that of wild-type enzyme. Although E137A had a similar afﬁnity
for the alkylglycerol substrate as that of the wild-type enzyme,
we observed a 5-fold weaker binding of iron by this mutant.
This was less pronounced than the 18-fold effect of the mutation
on the Km value for tetrahydrobiopterin. Therefore the increased
Km value for tetrahydrobiopterin in E137A is unlikely to be a
secondary effect caused by the decrease in iron afﬁnity only.
The effect of the tetrahydrobiopterin-afﬁnity-lowering mutation
E286A in phenylalanine hydroxylase on iron afﬁnity had not
been investigated previously. We therefore applied a similar
phenanthrolinecompetitionassaytowild-typeandE286Amutant
recombinant rat phenylalanine hydroxylase for comparative
purposes. We also found that, in phenylalanine hydroxylase,
mutation of the tetrahydrobiopterin-binding Glu
286 to alanine
reduced iron afﬁnity, although to a lesser extent (2.5-fold). The
IC50 values for phenanthroline we observed in the present study
for wild-type recombinant rat phenylalanine hydroxylase agree
well with previous results of phenanthroline inhibition of native
phenylalanine hydroxylase puriﬁed from rat liver [28].
It might be no coincidence that in both enzymes,
alkylglycerol mono-oxygenase and phenylalanine hydroxylase,
both tetrahydrobiopterin-interacting glutamate residues are
adjacent to an essential histidine residue, followed by a spacer
sequence of exclusively neutral amino acids and another essential
histidine residue. For all tetrahydrobiopterin-dependent aromatic
amino acid hydroxylases, the sequence environment of Glu
286 is
H-[DE]-[FILV]-[FILMVY]-G-H. This can be deduced from the
coreofthePDOC00316PROSITEmotif[29]whichrecognizesall
known enzymes of this type. For alkylglycerol mono-oxygenase,
in 11 animal species the consensus sequence around Glu
137 is
H-E-[ILV]-N-I-[FILM]-W-A-[AG]-H. In aromatic amino acid
hydroxylases, both of these conserved histidine residues bind
the catalytically active non-haem iron [27]. Alkylglycerol mono-
oxygenase also requires a non-haem iron [11], and the two
conserved histidine residues adjacent to Glu
137 are therefore
good candidates for iron interaction. Fatty acid hydroxylase
motif-containing proteins, however, use a di-iron centre for
catalysis[6].Thusironchelationandbiochemistrymightbemore
complex in alkylglycerol mono-oxygenase than in phenylalanine
hydroxylase.Noproteincontainingafattyacidhydroxylasemotif
other than alkylglycerol mono-oxygenase has ever been reported
to require tetrahydrobiopterin for catalysis. Intriguingly, none
of these enzymes except alkylglycerol mono-oxygenase has a
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Figure 5 Rosetta ab initio predicted partial structure of alkylglycerol mono-oxygenase
Three-dimensionalstructureofalkylglycerolmono-oxygenaseresiduesPro37–Ile205 includingﬁvetransmembraneregionspredictedusingtheRosettamembranemethod[7]visualizedusingPyMOL
(http://www.pymol.org). (A) Helical regions are shown in tube representation, and residues leading to inactivation of alkylglycerol mono-oxygenase upon mutation to alanine and Glu137 crucial for
tetrahydrobiopterin binding are highlighted as sticks. (B) Close-up of the suspected active site of alkylglycerol mono-oxygenase. All ﬁve modelled histidine residues of the eight-histidine motif as
well as Glu137 are found in close spatial proximity forming a shallow cavity ready to accommodate an iron cluster.
glutamate or aspartate residue adjacent to the conserved histidine
residueatthispositioninitsproteinsequence(seeSupplementary
Figure 7 in [4]).
Ab intio structure prediction using Rosetta membrane method
yielded a plausible three-dimensional model for residues 37–
205 of alkylglycerol mono-oxygenase. The structure presented
(Figure 5) provides a structural explanation for all loss of activity
mutations covered in the sequence, although this information was
not used for model generation. Three-dimensional positioning of
ﬁve histidine residues in close spatial proximity deﬁnes the local-
ization of the catalytically active iron cluster not included in the
actualmodel.TheﬂexibleGlu
137 providesabindingpartnerfortet-
rahydrobiopterinnexttotheironcluster,completingtheredoxsys-
tem of alkylglycerol mono-oxygenase. A putative binding site for
substrate ether lipids can be inferred from several apolar residues
near the active site. The consensus of ESKW, TMHMM, MEM-
SAT and Phobius estimate the ﬁfth transmembrane helix to range
from amino acid residues 194 to 214. In the ab initio structure,
however,thishelixrangesfrom183to201.Theabinitiostructure
is more plausible in this point, because His
201 in the ab initio
structure is not buried in the membrane, but becomes accessible
tothecatalyticregionoftheenzyme.Asdiscussedabove,His
201 is
conservedamongallfattyacidhydroxylasemotif-containingpro-
teins and is essential for alkylglycerol mono-oxygenase activity.
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Table S1 Forward and reverse primer sequences for introduction of mutations by QuikChange® site-directed mutagenesis
(a) Alkylglycerol mono-oxygenase
Mutation Forward primer (5 →3 ) Reverse primer (5 →3 )
D125A GCCTTCTTAGGAGTTGCCTTTGGCTACTACTGG CCAGTAGTAGCCAAAGGCAACTCCTAAGAAGGC
E137A CCATCGTATGGCGCATGCAGTTAATATTATGTGGGCC GGCCCACATAATATTAACTGCATGCGCCATACGATGG
Q146A ATGTGGGCCGGGCATGCAACACATCATAGTTCTGAAGAC GTCTTCAGAACTATGATGTGTTGCATGCCCGGCCCACAT
E152A CACATCATAGTTCTGCAGACTATAACTTATCCACAGC GCTGTGGATAAGTTATAGTCTGCAGAACTATGATGTG
D153A CACATCATAGTTCTGAAGCTTATAACTTATCCACAGCACTGAG CTCAGTGCTGTGGATAAGTTATAAGCTTCAGAACTATGATGTG
Q162A CTTATCCACAGCACTGCGCGCGTCTGTCCTCCAGATAT ATATCTGGAGGACAGACGCGCGCAGTGCTGTGGATAAG
Q166A CACTGAGACAGTCTGTCCTCGCGATATATACTTCCTGG CCAGGAAGTATATATCGCGAGGACAGACTGTCTCAGTG
Y174A CTTCCTGGATTTTCGCGAGTCCCCTGGCCCTCTTC GAAGAGGGCCAGGGGACTCGCGAAAATCCAGGAAG
H189A CCCCCTTCAGTATATGCTGTAGCGCTTCAATTCAATCTTCTTTACC GGTAAAGAAGATTGAATTGAAGCGCTACAGCATATACTGAAGGGGG
Q191A CCCCTTCAGTATATGCTGTTCATCTTGCATTCAATCTTCTTTACC GGTAAAGAAGATTGAATGCAAGATGAACAGCATATACTGAAGGGG
Q197A CTTCAATTCAATCTTCTTTACGCGTTTTGGATCCATACAGAGGTC GACCTCTGTATGGATCCAAAACGCGTAAAGAAGATTGAATTGAAG
H201A CTTTACCAATTTTGGATCGCTACAGAGGTCATCAATAACC GGTTATTGATGACCTCTGTAGCGATCCAAAATTGGTAAAG
E203A GGATCCATACAGCTGTCATCAATAACCTTGGTCC GGACCAAGGTTATTGATGACAGCTGTATGGATCC
E212A CCTTGGTCCTTTAGCGCTGATTCTTAATACTCCTAGCC GGCTAGGAGTATTAAGAATCAGCGCTAAAGGACCAAGG
H220A GATTCTTAATACTCCTAGCGCTCATAGGGTTCATCATGGCAG CTGCCATGATGAACCCTATGAGCGCTAGGAGTATTAAGAATC
Y230A CATGGCAGAAATCGTGCATGCATAGACAAAAATTATGCTGGTG CACCAGCATAATTTTTGTCTATGCATGCACGATTTCTGCCATG
C231A CATCATGGCAGAAATCGGTACGCCATAGACAAAAATTATGCTGG CCAGCATAATTTTTGTCTATGGCGTACCGATTTCTGCCATGATG
D233A CATGGCAGAAATCGTTATTGCATCGCGAAAAATTATGCTGGTGTTC GAACACCAGCATAATTTTTCGCGATGCAATAACGATTTCTGCCATG
N235A GGCAGAAATCGTTATTGCATAGACAAAGCTTATGCTGGTGTTC GAACACCAGCATAAGCTTTGTCTATGCAATAACGATTTCTGCC
Y236A CGTTATTGCATAGACAAAAATGCGGCCGGTGTTCTTATTATTTGGG CCCAAATAATAAGAACACCGGCCGCATTTTTGTCTATGCAATAACG
Y338A CATCTCAGCTATTAAAGATAGCTACAGTTGTACAGTTTGCTCTG CAGAGCAAACTGTACAACTGTAGCTATCTTTAATAGCTGAGATG
W243A GCTGGTGTTCTTATTATTGCGGATAAGATTTTTGGGACATTTGAAGC GCTTCAAATGTCCCAAAAATCTTATCCGCAATAATAAGAACACCAGC
D244A GCTGGTGTTCTTATTATTTGGGCTAAGATTTTTGGGACATTTGAAGC GCTTCAAATGTCCCAAAAATCTTAGCCCAAATAATAAGAACACCAGC
D384A GACTTCCATTGGATTTCTGCTAGCTCAAAGACCCAAGGCAGC GCTGCCTTGGGTCTTTGAGCTAGCAGAAATCCAATGGAAGTC
R396A GGCAGCTATTATGGAAACTCTCGCATGCTTGATGTTCTTAATGC GCATTAAGAACATCAAGCATGCGAGAGTTTCCATAATAGCTGCC
C397A GGAAACTCTCCGAGCGCTGATGTTCTTAATGCTGTACCG CGGTACAGCATTAAGAACATCAGCGCTCGGAGAGTTTCC
(b) Phenylalanine hydroxylase
Mutation Forward primer (5 →3 ) Reverse primer (5 →3 )
E286A CCTGAACCTGACATCTGCCACGCGTTGTTGGGACATGTGCC GGCACATGTCCCAACAACGCGTGGCAGATGTCAGGTTCAGG
Received 22 August 2011/22 December 2011; accepted 6 January 2012
Published as BJ Immediate Publication 6 January 2012, doi:10.1042/BJ20111509
1 To whom correspondence should be addressed (email ernst.r.werner@i-med.ac.at).
c   The Authors Journal compilation c   2012 Biochemical Society © 2012 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.